GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jamjoom Pharmaceuticals Factory Co (SAU:4015) » Definitions » Gross Profit

Jamjoom Pharmaceuticals Factory Co (SAU:4015) Gross Profit : ﷼781 Mil (TTM As of Sep. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Jamjoom Pharmaceuticals Factory Co Gross Profit?

Jamjoom Pharmaceuticals Factory Co's gross profit for the three months ended in Sep. 2024 was ﷼194 Mil. Jamjoom Pharmaceuticals Factory Co's gross profit for the trailing twelve months (TTM) ended in Sep. 2024 was ﷼781 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Jamjoom Pharmaceuticals Factory Co's gross profit for the three months ended in Sep. 2024 was ﷼194 Mil. Jamjoom Pharmaceuticals Factory Co's Revenue for the three months ended in Sep. 2024 was ﷼328 Mil. Therefore, Jamjoom Pharmaceuticals Factory Co's Gross Margin % for the quarter that ended in Sep. 2024 was 59.35%.

Jamjoom Pharmaceuticals Factory Co had a gross margin of 59.35% for the quarter that ended in Sep. 2024 => Durable competitive advantage

During the past 4 years, the highest Gross Margin % of Jamjoom Pharmaceuticals Factory Co was 64.79%. The lowest was 61.59%. And the median was 64.23%.


Jamjoom Pharmaceuticals Factory Co Gross Profit Historical Data

The historical data trend for Jamjoom Pharmaceuticals Factory Co's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jamjoom Pharmaceuticals Factory Co Gross Profit Chart

Jamjoom Pharmaceuticals Factory Co Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Gross Profit
513.30 474.69 593.92 703.79

Jamjoom Pharmaceuticals Factory Co Quarterly Data
Dec20 Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 187.23 118.86 249.40 218.18 194.41

Competitive Comparison of Jamjoom Pharmaceuticals Factory Co's Gross Profit

For the Drug Manufacturers - Specialty & Generic subindustry, Jamjoom Pharmaceuticals Factory Co's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Jamjoom Pharmaceuticals Factory Co's Gross Profit Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Jamjoom Pharmaceuticals Factory Co's Gross Profit distribution charts can be found below:

* The bar in red indicates where Jamjoom Pharmaceuticals Factory Co's Gross Profit falls into.



Jamjoom Pharmaceuticals Factory Co Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Jamjoom Pharmaceuticals Factory Co's Gross Profit for the fiscal year that ended in Dec. 2023 is calculated as

Gross Profit (A: Dec. 2023 )=Revenue - Cost of Goods Sold
=1100.819 - 397.03
=704

Jamjoom Pharmaceuticals Factory Co's Gross Profit for the quarter that ended in Sep. 2024 is calculated as

Gross Profit (Q: Sep. 2024 )=Revenue - Cost of Goods Sold
=327.576 - 133.17
=194

Gross Profit for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ﷼781 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

Jamjoom Pharmaceuticals Factory Co's Gross Margin % for the quarter that ended in Sep. 2024 is calculated as

Gross Margin % (Q: Sep. 2024 )=Gross Profit (Q: Sep. 2024 ) / Revenue (Q: Sep. 2024 )
=(Revenue - Cost of Goods Sold) / Revenue
=194 / 327.576
=59.35 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Jamjoom Pharmaceuticals Factory Co  (SAU:4015) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Jamjoom Pharmaceuticals Factory Co had a gross margin of 59.35% for the quarter that ended in Sep. 2024 => Durable competitive advantage


Jamjoom Pharmaceuticals Factory Co Gross Profit Related Terms

Thank you for viewing the detailed overview of Jamjoom Pharmaceuticals Factory Co's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


Jamjoom Pharmaceuticals Factory Co Business Description

Traded in Other Exchanges
N/A
Address
P.O. Box No. 6267, Jeddah, SAU, 21442
Jamjoom Pharmaceuticals Factory Co is engaged in the development, manufacture, and marketing of a wide range of high-quality branded generic pharmaceuticals, including pharmaceuticals and consumer health products, with the majority of revenue coming from pharmaceutical sales. Geographically the company has a presence in the Kingdom of Saudi Arabia, the Gulf, Iraq, Egypt, North Africa, and other export markets.

Jamjoom Pharmaceuticals Factory Co Headlines

No Headlines